CBUS
Cibus, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
40.04
P/S
23.88
EV/EBITDA
-5.60
DCF Value
$-0.65
FCF Yield
-58.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.9%
Operating Margin
-2429.6%
Net Margin
-3492.3%
ROE
-236.8%
ROA
-41.7%
ROIC
-30.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.1M | $-31.3M | $-0.39 |
| FY 2025 | $3.6M | $-127.1M | $-2.78 |
| Q3 2025 | $615.0K | $-23.5M | $-0.44 |
| Q2 2025 | $933.0K | $-25.4M | $-0.61 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.93
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.